United Kingdom Life Science Tools Market Size, Share, and COVID-19 Impact Analysis, By Type (Instruments, Consumables, Services), By Technology (Cell Culture Systems and 3D Cell Culture, PCR and qPCR, Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, and Others), By Application (Proteomics Technology, Genomic Technology, Cell Biology Technology, and Others), By End User (Government and Academic, Biopharmaceutical Company, Healthcare, Industrial Applications, and Others), and United Kingdom Life Science Tools Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareUnited Kingdom Life Science Tools Market Insights Forecasts to 2035
- The United Kingdom Life Science Tools Market Size was estimated at USD 7.68 Billion in 2024
- The Market Size is Expected to Grow at a CAGR of around 5.33% from 2025 to 2035
- The United Kingdom Life Science Tools Market Size is Expected to Reach USD 13.59 Billion by 2035
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, The United Kingdom Life Science Tools Market Size is anticipated to reach USD 13.59 Billion by 2035, growing at a CAGR of 5.33% from 2025 to 2035. The rapid growth of genetic engineering and biotechnology, rising R&D expenditures, the increasing incidence of chronic disease, the inclusion of digital technologies, and an urgent need for epidemic preparedness are all contributing factors to the market's strong expansion.
Market Overview
The UK life science tools market refers to the sector that focuses on the production, application, and distribution of advanced technologies that support biological research, diagnostics, and drug development. It includes next-generation sequencing, mass spectrometry, and flow cytometry, among other tools for genomes, proteomics, and cell biology. The life science tools market in the UK is driven by novel innovation through collaborations with businesses and academic institutions. Further, cutting-edge technologies and substantial investment for increasing research capacity and drive the expansion of the life science instruments market across the country. There are opportunities in the development of genomics and customized medicine, both of which are now gaining popularity in the UK, that are addressing the importance of life science tools. Further, development news like the UK government announced a £100 million investment to accelerate AI-driven advancements in life sciences and healthcare in December 2023. This initiative, called the AI Life Sciences Accelerator Mission, aims to leverage AI for breakthrough treatments in areas like dementia and cancer.
Report Coverage
This research report categorizes the market for the United Kingdom life science tools market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom life science tools market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom life science tools market.
United Kingdom Life Science Tools Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 7.68 Billion |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | CAGR of 5.33% |
2035 Value Projection: | USD 13.59 Billion |
Historical Data for: | 2020-2023 |
No. of Pages: | 237 |
Tables, Charts & Figures: | 116 |
Segments covered: | By Type, By Technology, By Application and By End User |
Companies covered:: | Abzena, Adaptimmune Therapeutics, AMS Biotechnology (AMSBIO), Evotec, Illumina, Oxford Instruments plc, Qiagen, and Others |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The market for UK life science tools is influenced by the growing need for novel life science instruments due to increasing investments by biotechnology and pharmaceutical firms, especially in the UK's research environment. Further, research and innovation are encouraged by government support, which shows the UK's prominent position in the life sciences industry worldwide. The development and commercialization of novel life science technologies are made possible by this support. Furthermore, the development of digital technologies like big data analytics and artificial intelligence has drastically changed and boosted this market expansion.
Restraining Factors
The market suffers a variety of barriers, including a shortage for competent workers, the high price of modern technology, and regulatory hurdles.
Market Segmentation
The United Kingdom life science tools market share is classified into type, technology, application, and end user.
- The instruments segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The United Kingdom life science tools market is segmented by type into instruments, consumables, and services. Among these, the instruments segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment expansion is influenced by an extensive variety of advanced gadgets that are necessary for many studies and diagnostic applications, tools hold a dominant position in the life science tools market projection period. Furthermore, the growing emphasis on incorporating automation, digitization, and artificial intelligence (AI) technologies to improve the instruments' accuracy, efficiency, and usefulness is driving the growth of the life science tools market.
- The cell culture systems and 3D cell culture segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
The United Kingdom life science tools market is divided by technology into cell culture systems and 3D cell culture, PCR and qPCR, Sanger sequencing, separation technologies, flow cytometry, nucleic acid microarray, mass spectrometry, and others. Among these, the cell culture systems and 3D cell culture segment dominated in 2024 and is projected to grow at a substantial CAGR during the forecast period. This is because research projects examining the possibilities of cell biology have produced significant breakthroughs, which have helped to understand cell biology. Additionally, the segment is anticipated to be further strengthened by the eagerness of life science professionals to use new and improved instruments for the expansion of the instrument portfolios with prompted by this market trend.
- The genomic technology segment held a significant share in 2024 and is anticipated to grow at a rapid pace during the forecast period.
The United Kingdom life science tools market is segmented by application into proteomics technology, genomic technology, cell biology technology, and others. Among these, the genomic technology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because it provides several benefits by enhancing illness prevention, enabling individualized care, and increasing diagnostic precision. Further, this is an important field that helps researchers comprehend genetic variations in genomic technology, which makes precision medicine and individualized healthcare possible.
- The government and academic segment accounted for a significant share in 2024 and is expected to grow at a rapid pace over the forecast period.
The United Kingdom life science tools market is classified by end user into government and academic, biopharmaceutical company, healthcare, industrial applications, and others. Among these, the government and academic segment accounted significant share in 2024 and is expected to grow at a rapid pace over the forecast period. This is due to their increasing reliance on a range of life science tools for doing ground-breaking research, creating novel treatment approaches, and advancing scientific understanding. The government and academic portion is another crucial area since both public and private institutions prioritize and emphasize the advancement of scientific research and the comprehension of disorders, which greatly aids in the use of life science tools & technologies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom life science tools market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Abzena
- Adaptimmune Therapeutics
- AMS Biotechnology (AMSBIO)
- Evotec
- Illumina
- Oxford Instruments plc
- Qiagen
- Others
Recent Developments:
- In January 2025, Clarivate launched DRG Fusion, a new life sciences analytics platform designed to support commercial analytics in the industry. This innovative tool is powered by real-world data and aims to help biopharma and medtech organizations navigate complex disease and a competitive landscape.
- In December 2024, ACG Inspection launched Life Sciences Cloud, an advanced analytics and traceability solution designed to enhance data insights for pharmaceutical businesses. This platform provided end-to-end supply chain traceability, helping companies improve manufacturing efficiency, production quality, and regulatory compliance.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom life science tools market based on the below-mentioned segments:
United Kingdom Life Science Tools Market, By Type
- Instruments
- Consumables
- Services
United Kingdom Life Science Tools Market, By Technology
- Cell Culture Systems and 3D Cell Culture
- PCR and qPCR
- Sanger Sequencing
- Separation Technologies
- Flow Cytometry
- Nucleic Acid Microarray
- Mass Spectrometry
- Others
United Kingdom Life Science Tools Market, By Application
- Proteomics Technology
- Genomic Technology
- Cell Biology Technology
- Others
United Kingdom Life Science Tools Market, By End User
- Government and Academic
- Biopharmaceutical Company
- Healthcare
- Industrial Applications
- Others
Need help to buy this report?